Catalent is up 23.7%, or $13.29 to $69.34.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CTLT:
- CTLT Soars on Danaher Interest; Will Publish Q2 Numbers Tomorrow
- Premium required for any Catalent-Danaher deal ‘up for debate,’ says BofA
- Danaher has expressed takeover interest in Catalent, Bloomberg says
- Catalent price target lowered to $58 from $62 at Barclays
- Catalent appoints Zayas as SVP, Operations, Biologics North America